A multi-institutional feasibility study of S-1/oxaliplatin plus bevacizumab in patients with advanced/metastatic colorectal cancer: the HiSCO-02 prospective phase II study.
Shimomura M, Shinozaki K, Hinoi T, Yoshimitsu M, Kurayoshi M, Sumitani D, Ishizaki Y, Oshiro T, Kodama S, Shimizu Y, Arita M, Tokunaga M, Yoshida M, Tanaka J, Ohdan H; Hiroshima Surgical study group of Clinical Oncology (HiSCO).
Shimomura M, et al. Among authors: hinoi t.
Springerplus. 2016 Oct 18;5(1):1800. doi: 10.1186/s40064-016-3491-8. eCollection 2016.
Springerplus. 2016.
PMID: 27803845
Free PMC article.